Title : Targeted therapies: PARP inhibitor olaparib is safe and effective in patients with BRCA1 and BRCA2 mutations.

Pub. Date : 2010 Oct

PMID : 20922827






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Targeted therapies: PARP inhibitor olaparib is safe and effective in patients with BRCA1 and BRCA2 mutations. olaparib collagen type XI alpha 2 chain Homo sapiens